ReviewDrugs2024
The Utilization of the Accelerated Approval Pathway in Oncology: A Case Study of Pembrolizumab.
Robert Kester et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it
ReviewDrugs2024
Robert Kester et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.